Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

ACRS Aclaris Therapeutics Inc

4,07

0,25 (6,54%)

29 Nov 2024 - Fermé

Retardé de 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Aclaris Therapeutics (NASDAQ:ACRS)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024

Plus de graphiques de la Bourse Aclaris Therapeutics

Aclaris Therapeutics (NASDAQ:ACRS)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024

Plus de graphiques de la Bourse Aclaris Therapeutics

Actualités Aclaris Therapeutics Inc

Form S-8 - Securities to be offered to employees in employee benefit plans
Mercredi 27 Novembre 2024 ( il y a 3 jours) • Edgar (US Regulatory)

Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Mardi 26 Novembre 2024 ( il y a 4 jours) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Lundi 25 Novembre 2024 ( il y a 5 jours) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Lundi 25 Novembre 2024 ( il y a 5 jours) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Vendredi 22 Novembre 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jeudi 21 Novembre 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 20 Novembre 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

This Healthcare Stock Soared Following Exclusive License Agreement Announcement
Mardi 19 Novembre 2024 ( il y a 2 semaines) • AllPennyStocks.com

Form 3 - Initial statement of beneficial ownership of securities
Lundi 18 Novembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
Lundi 18 Novembre 2024 ( il y a 2 semaines) • PR Newswire (US)

Form 8-K - Current report
Lundi 18 Novembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Aclaris Therapeutics Announces $80 Million Private Placement
Lundi 18 Novembre 2024 ( il y a 2 semaines) • GlobeNewswire Inc.

Plus d'articles sur Aclaris Therapeutics Inc

JP Morgan Chase

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales